Literature DB >> 3533257

Isolation and dissociation of immune complexes from pleural effusions of lymphoma patients.

G V Patel, M N Satam, G R Nadkarni, J J Nadkarni.   

Abstract

Immune complexes (IC) isolated from pleural effusions of lymphomas with favorable and unfavorable prognoses were of IgG type. These IC were further dissociated by ion exchange chromatography using 8 M urea. The antibody was found to be a high molecular weight protein (1.5 X 10(5) daltons) and reacted with antihuman IgG immunologically while a second peak obtained on ion exchange chromatography may be an antigen moiety with a molecular weight of 3.2 X 10(4) daltons as it reacted immunologically with the antibody. Strong cytoplasmic fluorescence was observed with various cell suspensions of lymphomas when reacted with the antibody preparations. The antisera raised against two different antigen fractions prepared from two lymphomas--nHL and LL showed positive fluorescence with both nHL and LL suspensions. The absorption of these rabbit antibodies with individual cell extracts or with antigen preparations also entirely blocked the cytoplasmic staining. The antigen moiety (PK-II) may have a common origin in the disease process. Pleural effusions from patients with unfavorable and favorable prognoses showed identical patterns of separation of IC components.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3533257     DOI: 10.1007/bf00205555

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  15 in total

1.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

2.  Characterization of immune complexes from the pleural effusion of a breast cancer patient.

Authors:  L D Papsidero; S R Harvey; M C Snyderman; T Nemoto; L Valenzuela; T M Chu
Journal:  Int J Cancer       Date:  1978-06-15       Impact factor: 7.396

3.  A place for soluble immune complexes in clinical immunology.

Authors:  U E Nydegger
Journal:  Immunol Today       Date:  1985-03

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Recovery of immunologically reactive antibodies and antigens from breast cancer immune complexes by preparative isoelectric focusing.

Authors:  B W Maidment; L D Papsidero; T Nemoto; T M Chu
Journal:  Cancer Res       Date:  1981-03       Impact factor: 12.701

6.  Isoelectric focusing--a new approach to the study of immune complexes.

Authors:  B W Maidment; L D Papsidero; T M Chu
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

7.  Activity of antibodies recovered from immune complexes of ovarian cancer patients.

Authors:  P M Lutz; J R Dawson
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

8.  Circulating immune complexes in patients with lymphomas and leukemias.

Authors:  G V Patel; R Gopal; J J Nadkarni
Journal:  Neoplasma       Date:  1984       Impact factor: 2.575

Review 9.  Immune complexes and human neoplasia. I.

Authors:  F A Salinas; K H Wee
Journal:  Biomed Pharmacother       Date:  1983       Impact factor: 6.529

10.  Isolation of lung carcinoma-associated antibodies from immune complexes and production of heterologous antisera.

Authors:  W J Cronin; B H Dorsett; H L Ioachim
Journal:  Cancer Res       Date:  1982-01       Impact factor: 12.701

View more
  1 in total

1.  In vitro modulation of natural killer cell activity in non-Hodgkin's lymphoma patients after therapy.

Authors:  B A Mehta; M N Satam; S H Advani; J J Nadkarni
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.